Global Intravascular Lithotripsy (IVL) Market Set to Surpass US$ 1197.5 Million by 2031, Key Insights and Growth Projections from Persistence Market Research

Overview of the Market

The global intravascular lithotripsy (IVL) market has been expanding rapidly and is projected to continue on this growth trajectory. Estimated to reach a market value of US$ 1,197.5 million by 2031 from US$ 489.1 million in 2024, the intravascular lithotripsy market is expected to witness a robust compound annual growth rate (CAGR) of 11.7% from 2024 to 2031. IVL is an innovative procedure that utilizes shockwaves to break down calcified plaques in arteries, enhancing blood flow and enabling better stent placement, making it an ideal treatment for patients suffering from cardiovascular diseases (CVD), especially those with calcified lesions. As cardiovascular diseases continue to rise globally, this non-invasive technique has gained substantial traction, further accelerating the IVL market growth.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/32139

Key growth drivers for the IVL market include the increasing prevalence of vascular calcification, particularly among the elderly population, who are more likely to suffer from calcified arterial problems. Additionally, the increasing preference for minimally invasive procedures, which require shorter recovery times and offer reduced complications, has been a significant factor fueling the adoption of IVL technology. The demand for IVL is also further propelled by its ability to treat older patients who may not be able to undergo traditional surgical treatments.

In terms of market segments, North America leads the global IVL market, accounting for a substantial share of 40.1% in 2024. This dominance is attributed to the region's well-established healthcare infrastructure, high rates of cardiovascular diseases, and the increasing adoption of advanced, minimally invasive treatment options. Moreover, coronary intravascular lithotripsy systems dominate the market, contributing 61.2% in 2024, due to their effectiveness in treating complex coronary calcifications.

Key Highlights from the Report

✦ North America leads the IVL market with a share of 40.1%, driven by advanced healthcare infrastructure and rising cardiovascular disease incidence.
✦ Coronary intravascular lithotripsy systems contribute the largest market share at 61.2%, attributed to their efficacy in treating complex coronary calcifications.
✦ The coronary artery disease (CAD) segment holds the largest application share of 54.1%, owing to the increasing prevalence of CAD and advancements in treatment technology.
✦ The prevalence of vascular calcification, particularly among the elderly, is a key driver for IVL market growth.
✦ Patient preference for minimally invasive cardiovascular treatments continues to fuel the demand for IVL systems, particularly in the U.S.
✦ Integration of imaging technologies like IVUS and OCT with IVL systems enhances procedural precision and patient safety.

Market Segmentation

The intravascular lithotripsy (IVL) market is segmented based on various factors, including product type, application, and end-user. These segments play a crucial role in determining the market's overall dynamics.

Product Type: The IVL market is primarily categorized into coronary intravascular lithotripsy systems, peripheral intravascular lithotripsy systems, and others. Among these, coronary intravascular lithotripsy systems are the largest contributor, as they account for over 60% of the market share. These systems are most commonly used for treating coronary artery diseases, particularly those associated with calcified coronary lesions. Peripheral IVL systems are growing in adoption, driven by advancements in vascular disease treatments.

Application: The coronary artery disease (CAD) segment dominates the application landscape, holding over 50% of the market share. This is due to the high prevalence of CAD globally and the increasing awareness regarding the importance of early detection and treatment. The peripheral artery disease (PAD) and other application segments are also gaining traction, although at a slower pace than CAD.

End-User: Hospitals and specialized cardiovascular centers are the primary end-users for IVL systems, due to their advanced treatment capabilities and the increasing number of cardiovascular procedures. The rise in the number of outpatient treatments and minimally invasive surgeries is pushing healthcare providers to invest in IVL systems to enhance patient outcomes.

Regional Insights

The IVL market shows varied trends across different regions, with North America leading the charge. The region's dominance can be attributed to the widespread prevalence of cardiovascular diseases, advanced healthcare systems, and supportive reimbursement policies. Additionally, the U.S. market has been witnessing the rapid adoption of innovative technologies such as IVL, further bolstered by an aging population and increased healthcare spending.

Europe follows North America in terms of market share, largely due to the prevalence of vascular calcification and coronary artery diseases across the region. The expansion of healthcare infrastructure and advancements in minimally invasive treatment options have been pivotal in driving the IVL market in Europe.

The Asia-Pacific region, particularly emerging markets like India and China, presents a significant growth opportunity. As healthcare infrastructure improves and awareness about cardiovascular diseases rises, the demand for IVL systems is expected to increase. The rising geriatric population and growing healthcare expenditure will contribute to the expansion of the IVL market in these regions.

Market Drivers

Several factors are driving the growth of the intravascular lithotripsy (IVL) market. One of the primary drivers is the increasing prevalence of vascular calcification, particularly among the aging population. Vascular calcification leads to arterial stiffening, which increases the risk of heart attacks, strokes, and other cardiovascular events. As the elderly population grows globally, the demand for effective treatments such as IVL is expected to rise.

Another key driver is the growing patient preference for minimally invasive cardiovascular treatments. Patients are increasingly opting for procedures that minimize recovery times and reduce the risk of complications. IVL technology, which provides a non-invasive alternative to traditional methods, aligns perfectly with this trend. The enhanced patient outcomes, lower risks of complications, and shorter recovery times make IVL a preferred choice in cardiovascular treatments.

Furthermore, the integration of imaging technologies such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) with IVL procedures enhances procedural precision, ensuring better treatment outcomes and fewer complications. These advancements in IVL technology will continue to drive its adoption across healthcare institutions.

Market Restraints

While the intravascular lithotripsy (IVL) market has significant growth potential, it faces certain challenges. One of the most prominent restraints is the high cost of IVL devices. Due to the advanced technology involved in the creation of these systems, they are expensive, making them unaffordable for many healthcare institutions, especially those in developing countries or areas with limited healthcare resources. The high cost is often passed on to patients, limiting accessibility.

Additionally, insurance coverage for IVL procedures may be limited, and the lack of widespread reimbursement policies could further hinder the adoption of IVL devices. These factors contribute to the overall cost barrier that limits the accessibility of IVL treatment for a significant portion of the patient population, especially in low-income and developing regions.

Market Opportunities

Emerging healthcare markets in regions like Asia-Pacific and Latin America present lucrative opportunities for the IVL market. As healthcare infrastructure in these regions continues to develop and more patients seek treatment for cardiovascular diseases, the demand for advanced medical technologies like IVL will increase. Governments and healthcare providers are focusing on expanding access to innovative treatments, creating a favorable environment for IVL adoption.

The integration of imaging technologies into IVL procedures also presents significant opportunities. With the potential for better precision and improved clinical outcomes, the combination of IVL and imaging modalities like IVUS and OCT is expected to become a standard practice, particularly in developed regions. The growing preference for accurate, real-time imaging to guide treatment is expected to boost the demand for advanced IVL systems.

Reasons to Buy the Report

✔ Comprehensive Market Analysis: Gain insights into the current and projected market trends, growth factors, and potential challenges affecting the IVL market.
✔ Detailed Market Segmentation: Understand the various market segments based on product type, application, and geography for better business decision-making.
✔ Competitive Landscape: Identify key players in the market and analyze their strategies for success.
✔ Regional Insights: Explore the IVL market trends across different regions and uncover new growth opportunities.
✔ Market Forecasting: Get detailed future market predictions to guide your investments and business strategies.

Company Insights

• Shockwave Medical, Inc.
• Medtronic
• Boston Scientific Corporation
• Philips Healthcare
• Straub Medical AG

Recent Developments in the Market

Shockwave Medical received an FDA approval for its IVL technology to treat peripheral artery disease (PAD) in addition to coronary artery disease (CAD), expanding the product's market reach.

Medtronic launched a new generation of coronary IVL systems, designed to offer more precise shockwave delivery and enhance the treatment of calcified coronary lesions.

Conclusion

The global intravascular lithotripsy (IVL) market is poised for significant growth due to the increasing prevalence of vascular calcification, a rising aging population, and the growing demand for minimally invasive procedures. While challenges such as high device costs persist, emerging markets and technological advancements present substantial growth opportunities for IVL systems. As healthcare providers continue to prioritize patient-centric, non-invasive treatment options, the IVL market is expected to expand, offering innovative solutions for cardiovascular disease management and improving patient outcomes worldwide.

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web:
https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.